Tiate, Rusemi S.

HRN: 25-90-48  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2025
CEFUROXIME 1.5GM (VIAL)
09/09/2025
09/10/2025
IVT
1.5g
Q8
S/p CS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Compliant To Guidelines